HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yeon-Jeong Kim Selected Research

Yeon-Jeong Kim Research Topics

Disease

14Neoplasms (Cancer)
06/2020 - 08/2007
5Infections
11/2018 - 09/2005
3Virus Diseases (Viral Diseases)
01/2015 - 08/2007
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 06/2005
2Obesity
06/2020 - 01/2018
2Insulin Resistance
06/2020 - 10/2018
2Inflammation (Inflammations)
01/2018 - 01/2008
2Hyperpigmentation
12/2015 - 01/2015
2Parkinson Disease (Parkinson's Disease)
05/2008 - 06/2005
2Neurodegenerative Diseases (Neurodegenerative Disease)
11/2006 - 06/2005
1Adenocarcinoma
01/2022
1Vestibular Neuronitis (Vestibular Neuritis)
12/2020
1Cerebellar Ataxia (Dysmetria)
12/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2019
1Body Weight (Weight, Body)
01/2016
1Type 2 Diabetes Mellitus (MODY)
04/2015
1Human Influenza (Influenza)
01/2015
1Melanoma (Melanoma, Malignant)
01/2015
1Pneumonia (Pneumonitis)
01/2015
1Bacillary Dysentery (Shigellosis)
01/2013
1Colonic Neoplasms (Colon Cancer)
12/2012
1Myocardial Infarction
10/2012
1ST Elevation Myocardial Infarction
10/2012
1Hypoxia (Hypoxemia)
12/2010
1Autoimmune Diseases (Autoimmune Disease)
06/2010
1Eosinophilia
05/2010
1Carcinoma (Carcinomatosis)
08/2007
1Breast Neoplasms (Breast Cancer)
08/2007

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2006
5CytokinesIBA
11/2018 - 12/2014
5VaccinesIBA
03/2016 - 06/2008
5alpha-galactosylceramideIBA
02/2009 - 08/2007
4Antiviral Agents (Antivirals)IBA
11/2018 - 01/2015
3Pharmaceutical PreparationsIBA
01/2019 - 01/2013
2Amyloid (Amyloid Fibrils)IBA
01/2021 - 06/2014
2Tyrosine (L-Tyrosine)FDA Link
06/2020 - 01/2018
2SphingolipidsIBA
06/2020 - 10/2018
2Monophenol Monooxygenase (Tyrosinase)IBA
12/2015 - 01/2015
2ThapsigarginIBA
12/2014 - 12/2012
2AntigensIBA
06/2008 - 08/2007
2Protein AggregatesIBA
11/2006 - 06/2005
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2006 - 06/2005
1Antineoplastic Agents (Antineoplastics)IBA
01/2022
1thiazolyl blueIBA
01/2022
1Replication Protein C (Replication Factor C)IBA
12/2020
1Biological ProductsIBA
06/2020
1astaxanthine (astaxanthin)IBA
04/2020
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
07/2019
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019
1pochonin DIBA
11/2018
1Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2018
1src-Family KinasesIBA
10/2018
1phosphatidylcholine-ceramide phosphocholine transferaseIBA
10/2018
1Insulin (Novolin)FDA Link
10/2018
1CeramidesIBA
10/2018
1DiglyceridesIBA
10/2018
1LipidsIBA
10/2018
1Transcription Factors (Transcription Factor)IBA
11/2016
1Interleukin-6 (Interleukin 6)IBA
10/2016
1Interleukin-10 (Interleukin 10)IBA
10/2016
1Itraconazole (Sporanox)FDA LinkGeneric
03/2016
1CholesterolIBA
03/2016
1ChemokinesIBA
03/2016
15,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA
01/2016
1Blood Glucose (Blood Sugar)IBA
01/2016
1daidzeinIBA
04/2015
1GenisteinIBA
04/2015
1IsoflavonesIBA
04/2015
1glyciteinIBA
04/2015
1EquolIBA
04/2015
1Biomarkers (Surrogate Marker)IBA
04/2015
1Oseltamivir (Tamiflu)FDA Link
01/2015
1Melanins (Melanin)IBA
01/2015
1Skin Lightening PreparationsIBA
01/2015
14-phenylbutyric acid (Buphenyl)FDA Link
12/2014
14-phenylbutylamineIBA
12/2014
1SolutionsIBA
01/2013
1Anti-Bacterial Agents (Antibiotics)IBA
01/2013
1Neoplasm Antigens (Tumor Antigens)IBA
12/2012
1mangostinIBA
12/2012
1Creatine Kinase (Creatine Phosphokinase)IBA
10/2012
1IsoenzymesIBA
10/2012
1ThioredoxinsIBA
10/2012
1Troponin T (Troponin T1)IBA
10/2012
1Oxidoreductases (Dehydrogenase)IBA
12/2010
1Monoclonal AntibodiesIBA
06/2010
1Immunoglobulin E (IgE)IBA
05/2010
1AllergensIBA
05/2010
1LigandsIBA
02/2009
1Therapeutic UsesIBA
06/2008
1Cancer VaccinesIBA
06/2008
1Phosphotransferases (Kinase)IBA
05/2008
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
05/2008
1Interleukin-17 (Interleukin 17)IBA
01/2008
1GemcitabineFDA Link
08/2007
1AutoantigensIBA
08/2007

Therapy/Procedure

2Immunotherapy
11/2016 - 08/2007
1Aftercare (After-Treatment)
01/2022
1Therapeutics
08/2013
1Percutaneous Coronary Intervention
10/2012